Tag: Eli Lilly and Co

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says

Novo Nordisk’s Wegovy weight loss drug approved in China

Interest rates and the AI-fueled rally remain top of mind for stock investors in the week ahead

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space

10-year Treasury yield is little changed after cool inflation data

Treasury yields fall as traders continue to assess prospects of futures Fed rate cuts